Neimeth cuts share premium to N390 million, transfers N1.99 billion to reserves 

AI Summary

Neimeth International Pharmaceuticals Plc has successfully completed a restructuring process that involves cutting its share premium account significantly and transferring a substantial amount to retained earnings. This decision was approved by shareholders in a recent meeting.

Shareholders of Neimeth International Pharmaceuticals Plc have approved a major capital restructuring scheme that will reduce the company’s share premium account from N2.38 billion to N390.02 million and transfer N1.99 billion to its retained earnings reserve.  The post Neimeth cuts share premium to N390 million, transfers N1.99 billion to reserves  appeared first on Nairametrics.